CGNT
Cognyte Software Ltd.
CGNT has the edge over INTC overall, supported by lower modeled downside.
INTC
Intel Corporation
INTC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CGNT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Strong |
CGNT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
CGNT PE Valuation
CGNT has no meaningful PE right now: it lost money over the past year.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
CGNT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CGNT, with profitability improving.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
CGNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.70 | — |
| Q3 2026 | -$0.00 | +$0.06 |
| Q2 2026 | -$0.04 | +$0.07 |
| Q1 2026 | -$0.01 | +$0.16 |
| Q4 2025 | -$0.08 | +$0.11 |
| Q3 2025 | -$0.06 | $0.00 |
| Q2 2025 | -$0.11 | +$0.06 |
| Q1 2025 | -$0.17 | +$0.03 |
| Q4 2024 | -$0.19 | +$0.38 |
CGNT has the edge over INTC on earnings, with more consistent year-over-year improvement.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
CGNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $109.2M | +12% |
| Q2 2026 | $105.5M | +10% |
| Q1 2026 | $106.2M | +12% |
| Q4 2025 | $100.7M | +13% |
| Q3 2025 | $97.5M | +16% |
| Q2 2025 | $95.5M | +16% |
| Q1 2025 | $94.5M | +13% |
| Q4 2024 | $89M | +12% |
CGNT has the edge over INTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.3% | +1.4 points |
| Q2 2026 | 4.2% | +1.9 points |
| Q1 2026 | 4.9% | +4.1 points |
| Q4 2025 | 3.2% | +5.6 points |
| Q3 2025 | 2.8% | +4.5 points |
| Q2 2025 | 2.3% | +5 points |
| Q1 2025 | 0.7% | +4.5 points |
| Q4 2024 | -2.4% | +1.1 points |
CGNT's operating margin was 4.3% last quarter, up 1.4 points from the same quarter a year ago.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over CGNT on profitability, with a higher operating margin.
CGNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.5M | +$7.4M |
| Q2 2026 | -$6.1M | -$3.7M |
| Q1 2026 | $19.2M | +33% |
| Q4 2025 | $22.8M | +199% |
| Q3 2025 | -$8.9M | -$836K |
| Q2 2025 | -$2.5M | -113% |
| Q1 2025 | $14.4M | +106% |
| Q4 2024 | $7.6M | +$9.9M |
CGNT usually generates cash, though not every quarter: the latest was −$1M, but it generated $34M over the past year.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over CGNT on cash flow, with more consistent year-over-year improvement.
CGNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.7x | Net Cash |
| Q2 2026 | -3.3x | Net Cash |
| Q1 2026 | -3.1x | Net Cash |
| Q4 2025 | -3.6x | Net Cash |
| Q3 2025 | -3.3x | Net Cash |
| Q2 2025 | -4.8x | Net Cash |
| Q1 2025 | -8.2x | Net Cash |
| Q4 2024 | -147.5x | Net Cash |
CGNT has the edge over INTC on leverage, with a lower net debt burden relative to earnings.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
CGNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 29.4 | Neutral |
CGNT's weekly RSI is 47 (neutral) and its Stochastic is 29 (neutral).
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CGNT PE vs Technology Sector
| Metric | CGNT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CGNT has no meaningful PE right now: it lost money over the past year.
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
CGNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.80 | 4.8% below |
| 20 week MA | $8.74 | 4.1% below |
| 50 week MA | $8.83 | 5.1% below |
| 100 week MA | $8.94 | 6.3% below |
| 200 week MA | $7.46 | 12% above |
CGNT has fallen below most of its moving averages, though it's still 12% above its 200-week average.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has the edge over CGNT on trend strength, trading above more of its moving averages.
CGNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $28.8 | $14.9 | -48% |
| 2022 | $14.9 | $2.75 | -82% |
| 2023 | $2.75 | $6.43 | +134% |
| 2024 | $6.43 | $8.77 | +36% |
| 2025 | $8.77 | $9.31 | +6.2% |
| 2026 YTD | $9.31 | $8.38 | -10% |
CGNT's yearly returns have swung widely, from +134% in 2023 to −82% in 2022. It's down 10% so far in 2026.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over CGNT on returns for 2026, with the stronger performance.